Celecoxib – Tramadol CC

Celecoxib – Tramadol CC

Celecoxib‐tramadol co‐crystal (CTC) has been developed as a multimodal treatment option for the management of acute pain severe enough to require an opioid. CTC contains tramadol, a μ‐opioid agonist and norepinephrine and serotonin reuptake inhibitor, plus the cyclooxygenase‐2 selective inhibitor celecoxib

Systematic Name

"4-[5-(4-Methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol"

Therapeutic Category

Management of acute pain

Suitable Formulations

Solid

Approvals

U/Development

Do You Have A Question? Lets Have A Talk

Sthree chemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.